by Richard L. Holt, MD; and R. Bruce Lydiard, PhD, MD
Dr. Holt is from the Medical University of South Carolina Department of Psychiatry; and Dr. Lydiard is from Southeast Health Consultants, LLC, Charleston, South Carolina.
by Alexander H. Fan, MD; and Stephen Fink, MD
Dr. Fan is a staff psychiatrist, Cedars-Sinai Medical Center, Los Angeles, California; Dr. Fink is with the Department of Anesthesiology, Stanford University.
by Jamie McLean, MD
Series Editor: Paulette M. Gillig, MD, PhD
Drs. McLean and Gillig are from the Department of Psychiatry, Boonshoft School of Medicine, Wright State University, Dayton, Ohio.
by John H. Montgomery, Do; and Devi Vasu, MD
Dr. Montgomery is from Mississippi State Hospital, Whitfield, Mississippi; and Dr. Vasu is from the Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, Mississippi.
With CATIE, context is key,
when sorting out Phases 1, 1A, 1B, 2E, and 2T
by Leslie Citrome, MD, MPH
Dr. Citrome is from the New York University School of Medicine, Department of Psychiatry, and the Nathan S. Kline Institute for Psychiatric Research, Orangeburg, New York.
by Ronald Pies, MD
Dr. Pies is Professor of Psychiatry, SUNY Upstate Medical University, Syracuse, New York; and Clinical Professor of Psychiatry, Tufts USM, Boston, Massachusetts.
by Elisa F. Cascade; Amir H. Kalali, MD; David Feifel, MD, PhD
Ms. Cascade is Vice President, Strategic Research and Safety, Quintiles Inc., Falls Church, Virginia; Dr. Kalali is Vice President, Global Therapeutic Group Leader CNS, Quintiles Inc., San Diego, California, and Professor of Psychiatry, University of California, San Diego; and Dr. Feifel is Associate Professor In Residence, Department of Psychiatry; Director, Neuropsychiatry and Behavioral Medicine Program; Director, UCSD Adult ADHD Program, University of California, San Diego Medical Center, San Diego, California.
